Ranibizumab for high-risk proliferative diabetic retinopathy: an exploratory randomized controlled trial
… During the remaining follow-up, if NV persisted or recurred, … be performed after 3 months of follow-up (6 months after the … variations during the study follow-up and the result was …..... Read More